Related Experiment Video
Updated: Oct 21, 2025

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.5K
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
Wei Chen1, Zhihao Wang2, Yawen Wang2,3
1Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Frontiers in Pharmacology
|September 6, 2021
Summary
Medicinal plants offer promising natural bioactive molecules for treating SARS-CoV-2 (the virus causing COVID-19) due to their antiviral properties. This review explores these compounds and their potential therapeutic applications.
Area of Science:
- Virology
- Pharmacology
- Natural Product Chemistry
Background:
- Coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, have caused severe global health crises.
- SARS-CoV-2 (COVID-19) has resulted in millions of deaths and significant economic disruption worldwide.
- Currently, no clinically validated antiviral drugs exist for SARS-CoV-2 treatment.
Purpose of the Study:
- To provide fundamental biological information on SARS-CoV-2, including its characteristics and invasion mechanisms.
- To review natural bioactive molecules with demonstrated anti-coronavirus activity.
- To discuss the therapeutic potential of these natural compounds for COVID-19 treatment.
Main Methods:
- Literature review of scientific publications on SARS-CoV-2 and natural bioactive molecules.
- Categorization of natural compounds based on their molecular targets within the viral life cycle.
- Analysis of viral and host proteins targeted by natural compounds, including PLpro, 3CLpro, RdRp, helicase, spike, ACE2, and TMPRSS2.
Main Results:
- Natural bioactive molecules from medicinal plants show potential as therapeutic agents against SARS-CoV-2.
- These compounds act on various stages of the viral life cycle and target key viral or host proteins.
- The review summarizes identified natural molecules and their specific anti-coronavirus mechanisms.
Conclusions:
- Natural bioactive molecules represent a viable strategy for developing novel antiviral therapies for SARS-CoV-2.
- Further research into these compounds could lead to effective treatments for COVID-19.
- Medicinal plants are a valuable resource for discovering new anti-coronavirus agents.
Keywords:
COVID-19SARS-CoV-2antiviral agentscoronavirusnatural bioactive moleculestherapeutic targetsMore Related Videos
Related Concept Videos
Conjugated Proteins
21.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.4K
siRNA - Small Interfering RNAs
17.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.3K
Microorganisms in Medicine and Therapeutics
523
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
523

